start portlet menu bar end portlet menu bar

Evaluation of an Erysipelothrix rhusiopathiae experimental infection In pigs vaccinated with ERYSENG®

Home Conoscenze Evaluation of an Erysipelothrix rhusiopathiae experimental infection In pigs vaccinated with ERYSENG®

Evaluation of an Erysipelothrix rhusiopathiae experimental infection In pigs vaccinated with ERYSENG®

The aim of this study was to demonstrate the efficacy of ERYSENG® in pigs against swine erysipelas after a challenge with two different E. rhusiopathiae virulent strains, corresponding to serotype 1 and serotype 2.

Scarica articolo

1,9 MB

Informazioni sull'articolo

Pubblicato in

ESPHM Congress, 2015

Autori

Simon-Grifé, M.; Guàrdia, M.; Roca, M.; Camprodon, A.; Pedrazuela, R.; Fontseca, M.; March, R.

Riepilogo

ERYSENG® administered by intramuscular route in pigs prevents the body temperature increase and the clinical signs produced by an experimental infection with two different E. rhusiopathiae virulent strains corresponding to serotype 1 and serotype 2.

Servizi correlati

HIPRA Diagnos

Prodotti correlati

ERYSENG®

Pubblicazioni correlate

Serological response to Erysipelothrix Rhusiopathiae in gilts receiving various commercialised vaccines Farrowing parameters enhancement in two brazilian farms using ERYSENG® PARVO/LEPTO vaccine Comparative study of the humoral response against swine erysipelas induced by ERYSENG® PARVO and another commercial vaccine under field conditions in Germany

Condividi

start portlet menu bar

Evaluation of an Erysipelothrix rhusiopathiae experimental infection In pigs vaccinated with ERYSENG®

Display portlet menu
end portlet menu bar

Vedi anche

Pubblicazioni

Intradermal application of vaccines in pigs (Poster)

04-10-2018
Malattia sintesi

Edema disease

03-11-2017
Notizie

HIPRA takes a step forward in Taiwan with the launch of UNISTRAIN® PRRS vaccine

11-10-2018